Insulet Corporation develops and manufactures the Omnipod, a line of tubeless, wearable insulin management systems designed for people with diabetes. The Omnipod provides continuous insulin delivery without the need for multiple daily injections, enhancing the quality of life for its users. The company operates globally, with a presence in 26 countries and a focus on innovation in medical devices. Insulet generates revenue primarily through the sale of its Omnipod systems and related products to individuals managing diabetes.
No recent RNS announcements for 1PODD across 1PODD, PODD.
No recent RNS announcements for 1PODD across 1PODD, PODD.